Zurich, Switzerland

Andreas Philipp Boudier

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Journey of Andreas Philipp Boudier

Introduction:

Andreas Philipp Boudier is a prominent inventor based in Zurich, Switzerland, with a notable contribution to the field of pharmaceuticals. With a portfolio of four patents, he has made significant strides in developing methods related to advanced compounds, particularly in the area of therapeutic agents.

Latest Patents:

Boudier's most recent patents focus on the preparation of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide, commonly known as pimavanserin. These patents encompass innovative methods that involve contacting specific intermediates to produce pimavanserin or its salt forms. The methodologies described in his patents are crucial for synthesizing this compound and its tartrate salt, enhancing the accessibility of effective treatments in pharmacology.

Career Highlights:

Andreas Boudier has an impressive career at Acadia Pharmaceuticals Inc., where he has been instrumental in advancing research and development. His expertise has directly contributed to the formulation of groundbreaking therapies aimed at treating complex medical conditions. With four patents under his name, Boudier stands out as a leader in pharmaceutical innovation.

Collaborations:

Throughout his career, Boudier has collaborated with talented colleagues such as Marlon Carlos and Sagun Tandel. Their combined efforts have fostered an environment of creativity and efficiency, leading to successful outcomes in their research endeavors.

Conclusion:

As an influential inventor, Andreas Philipp Boudier exemplifies the fusion of innovation and practical application in the pharmaceutical industry. His dedication to advancing methods for synthesizing key compounds emphasizes the importance of continual research and collaboration in the fight against diseases. With a strong patent portfolio, Boudier is poised to make further contributions that may significantly impact healthcare and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…